<DOC>
	<DOCNO>NCT01047488</DOCNO>
	<brief_summary>Polyneuropathy different etiology often associate pain standard treatment type pain gabapentinoids antidepressant . The hypothesis study combination gabapentinoid pregabalin antidepressant imipramine provide good pain relief single compound alone . This randomized , placebo-controlled , double-blind , 4-way , cross-over trial pregabalin 300 mg/day , imipramine 75 mg/day combination versus placebo . The study include 60 patient treatment outcome pain intensity measure numeric rating scale .</brief_summary>
	<brief_title>Imipramine Pregabalin Combination Painful Polyneuropathy</brief_title>
	<detailed_description />
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Imipramine</mesh_term>
	<criteria>Age 20 85 year . Characteristic symptom polyneuropathy least 6 month . Polyneuropathy diagnosis confirm typical clinical sign ( distal sensory disturbance/lack distal deep tendon reflex ) and/or electrophysiological test and/or abnormal quantitative sensory test . Total pain intensity rating least 4 010 point numeric rating scale . Pain present least 4 day week . For diabetic : diabetes diagnosis least 6 month stable metabolic control least 3 month . For secondary polyneuropathies : stable least 6 month . For fertile female : adequate anticonceptive treatment . Written informed consent . Other cause pain . Contraindications imipramine . Allergic reaction towards imipramine pregabalin . Known adverse reaction imipramine pregabalin treatment . Pregnancy . Severe systemic disease . Ongoing treatment antidepressant , antipsychotic , anticonvulsant , opioids , propranolol , kinidine , monoamine oxidase inhibitor . Inability follow study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>polyneuropathy</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>treatment</keyword>
</DOC>